Eczema Trial, Recruiting NCT06547372 Sponsor: National University of Singapore Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT06547372
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You currently have mild-to-moderate eczema (atopic dermatitis) in areas like the inside of your elbows or knees
  • You are between 21 and 65 years old (inclusive)
  • You can read and understand English and are able to give your consent in English
  • You live in Singapore and will not be travelling outside of Singapore during the study
  • You are willing and able to follow the study procedures for the full duration of the study
  • You do not smoke, including regular cigarettes or e-cigarettes
  • You do not drink alcohol regularly or frequently
  • You are generally healthy with no existing medical conditions such as diabetes, high blood pressure, cancer, blood disorders, liver disease, autoimmune conditions, kidney disease, or mental health conditions
  • You have no food allergies to the foods being tested in the study
  • You are comfortable with needles and do not have a needle phobia
  • You are willing to follow the research team's instructions about what moisturisers, cosmetics, or skin creams you use during the study

Who may not be able to join:

  • You are currently taking part in another research study
  • You are pregnant or currently breastfeeding
  • You have had a known psychiatric (mental health) disorder within the last 3 years
  • You have a known serious nutritional deficiency
  • You follow a vegetarian or vegan diet (as the study diet includes meat)
  • You have made a major change to your diet in the past 12 months
  • You have existing dietary restrictions that would make it difficult to follow a full study meal plan
  • You regularly take strong medications, whether Western medicine, traditional medicine, or alternative remedies
  • You have regularly taken nutritional supplements in the past 12 months, or regularly take oral contraceptive pills or steroid hormones
  • You have taken antibiotics in the past 2 months
  • You have had a long-term hospital stay or surgery in the 6 months before joining the study
  • Your weight has changed by more than 5% in the past month
  • You have a history of bleeding disorders or problems with blood clotting
  • You have donated more than 500 mL of blood within 4 weeks of joining the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fook Tim CHEW, PhD, NUS Singapore

Phone: 65163523

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National University of Singapore
Registry
ClinicalTrials.gov
Start date
10 May 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Healthy Dietary Intervention in Treating Atopic Dermatitis (Reducing SCORAD Scores)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov